Letter to the editor: Critical need for robust surveillance in response to DENV-2 and SARS-CoV-2 cross-reactivity.
作者信息
Kow Chia Siang, Ramachandram Dinesh Sangarran, Hasan Syed Shahzad, Thiruchelvam Kaeshaelya
机构信息
School of Pharmacy, International Medical University, Kuala Lumpur, Malaysia.
School of Pharmacy, Monash University Malaysia, Bandar Sunway, Selangor, Malaysia.
出版信息
Euro Surveill. 2024 May;29(19). doi: 10.2807/1560-7917.ES.2024.29.19.2400236.
Abstract
摘要
相似文献
1
Letter to the editor: Critical need for robust surveillance in response to DENV-2 and SARS-CoV-2 cross-reactivity.致编辑的信：应对登革热病毒2型和严重急性呼吸综合征冠状病毒2型交叉反应的强大监测的迫切需求。
Euro Surveill. 2024 May;29(19). doi: 10.2807/1560-7917.ES.2024.29.19.2400236.
2
Author's response: Critical need for robust surveillance in response to DENV-2 and SARS-CoV-2 cross-reactivity.作者回复：应对登革热病毒2型（DENV-2）和严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）交叉反应性，迫切需要进行强有力的监测。
Euro Surveill. 2024 May;29(19). doi: 10.2807/1560-7917.ES.2024.29.19.2400270.
3
Evaluation of Serologic Cross-Reactivity Between Dengue Virus and SARS-CoV-2 in Patients with Acute Febrile Illness - United States and Puerto Rico, April 2020-March 2021.2020 年 4 月至 2021 年 3 月期间美国和波多黎各急性发热性疾病患者中登革热病毒与 SARS-CoV-2 血清学交叉反应的评估
MMWR Morb Mortal Wkly Rep. 2022 Mar 11;71(10):375-377. doi: 10.15585/mmwr.mm7110a3.
4
Serological cross-reaction and coinfection of dengue and COVID-19 in Asia: Experience from Indonesia.亚洲登革热和 COVID-19 的血清学交叉反应和合并感染：来自印度尼西亚的经验。
Int J Infect Dis. 2021 Jan;102:152-154. doi: 10.1016/j.ijid.2020.10.043. Epub 2020 Oct 25.
5
Cross-reactivity of SARS-CoV-2 with other pathogens, especially dengue virus: A historical perspective.SARS-CoV-2 与其他病原体（尤其是登革热病毒）的交叉反应：历史视角。
J Med Virol. 2023 Feb;95(2):e28557. doi: 10.1002/jmv.28557.
6
Dengue virus (DV) non-cross-reactive Omicron wave COVID-19 serums enhanced DV3 infectivity .登革热病毒（DV）非交叉反应的奥密克戎波新冠病毒血清增强了 DV3 的感染力。
J Med Microbiol. 2024 Jul;73(7). doi: 10.1099/jmm.0.001852.
7
Evidences support that dengue virus can impart broad-spectrum immunity against betacoronaviruses in dengue endemic regions.有证据表明，在登革热流行地区，登革病毒可以对β冠状病毒产生广谱免疫。
J Med Virol. 2024 Jun;96(6):e29771. doi: 10.1002/jmv.29771.
8
Covid-19 and dengue: Double punches for dengue-endemic countries in Asia.Covid-19 和登革热：亚洲登革热流行国家的双重打击。
Rev Med Virol. 2021 Mar;31(2):e2161. doi: 10.1002/rmv.2161. Epub 2020 Sep 18.
9
Antibodies against the SARS-CoV-2 S1-RBD cross-react with dengue virus and hinder dengue pathogenesis.针对 SARS-CoV-2 S1-RBD 的抗体与登革热病毒发生交叉反应，并阻碍登革热发病机制。
Front Immunol. 2022 Aug 15;13:941923. doi: 10.3389/fimmu.2022.941923. eCollection 2022.
10
Anti-Arbovirus Antibodies Cross-React With Severe Acute Respiratory Syndrome Coronavirus 2.抗虫媒病毒抗体与严重急性呼吸综合征冠状病毒 2 发生交叉反应。
Microbiol Spectr. 2022 Dec 21;10(6):e0263922. doi: 10.1128/spectrum.02639-22. Epub 2022 Nov 29.
引用本文的文献
1
Author's response: Critical need for robust surveillance in response to DENV-2 and SARS-CoV-2 cross-reactivity.作者回复：应对登革热病毒2型（DENV-2）和严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）交叉反应性，迫切需要进行强有力的监测。
Euro Surveill. 2024 May;29(19). doi: 10.2807/1560-7917.ES.2024.29.19.2400270.
本文引用的文献
1
Molecular epidemiology identifies the expansion of the DENV2 epidemic lineage from the French Caribbean Islands to French Guiana and mainland France, 2023 to 2024.分子流行病学表明，2023 年至 2024 年期间，登革热病毒 2 型的流行谱系从法属加勒比群岛扩展到法属圭亚那和法国本土。
Euro Surveill. 2024 Mar;29(13). doi: 10.2807/1560-7917.ES.2024.29.13.2400123.
2
Understanding antibody-dependent enhancement in dengue: Are afucosylated IgG1s a concern?了解登革热中的抗体依赖性增强作用：去岩藻糖基化IgG1是否值得关注？
PLoS Pathog. 2023 Mar 30;19(3):e1011223. doi: 10.1371/journal.ppat.1011223. eCollection 2023 Mar.
3
Antibody-Dependent Enhancement (ADE) and the role of complement system in disease pathogenesis.抗体依赖的增强作用（ADE）及补体系统在疾病发病机制中的作用。
Mol Immunol. 2022 Dec;152:172-182. doi: 10.1016/j.molimm.2022.11.010. Epub 2022 Nov 10.
Zotero 插件